Ramses comparative claims "unsubstantiated" -- proposed FTC consent agreement.
This article was originally published in The Tan Sheet
Executive Summary
RAMSES COMPARATIVE CLAIMS BARRED BY PROPOSED FTC CONSENT AGREEMENT unless Norcross, Ga.-based London International "possesses and relies upon competent and reliable scientific evidence to back up the claims" for the latex condoms, the Federal Trade Commission reported Sept. 3. The consent agreement was spurred by advertising claims that Ramses is "30% stronger than the leading brand," which FTC called "unsubstantiated and deceptive."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning